GI
PBYI icon

GAMMA Investing’s Puma Biotechnology PBYI Stock Holding History

GAMMA Investing’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.9K Buy
1,094
+598
+121% +$5.26K ﹤0.01% 3281
2026
Q2 		$4.02K Buy
496
+74
+18% +$542 ﹤0.01% 3561
2026
Q1 		$2.7K Buy
422
+283
+204% +$1.82K ﹤0.01% 3572
2025
Q4 		$827 Buy
139
+61
+78% +$324 ﹤0.01% 3835
2025
Q3 		$414 Buy
+78
New +$331 ﹤0.01% 3737

Other funds holding PBYI

B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

GAMMA Investing's PBYI Position: Q3 2026 in Review

GAMMA Investing increased its Puma Biotechnology (PBYI) stake by 121% in Q3 2026, buying an estimated $5.26K and bringing the position to 1,094 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3281.

GAMMA Investing first reported a position in PBYI in Q3 2025 and has held it in 5 quarters since. 9 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • GAMMA Investing held 1,094 shares of Puma Biotechnology worth $10.9K as of Q3 2026.
  • GAMMA Investing bought 598 Puma Biotechnology shares in Q3 2026, an estimated $5.26K.
  • Puma Biotechnology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3281 holding.
  • GAMMA Investing first reported a position in Puma Biotechnology in Q3 2025 and has held it in 5 quarters since.
  • 9 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.